Ability Pharma is a Spanish biopharmaceutical company focused on developing innovative treatments, particularly in oncology. The company has developed drug candidates targeting various cancers and has conducted clinical trials for their therapeutic programs. Ability Pharma represents Spain's growing biotech sector and has worked on advancing novel compounds through preclinical and clinical development stages.
Ability Pharma has received investment from 1 venture capital firm.
Spanish biopharmaceutical company developing innovative treatments for oncology and other therapeutic areas.
Ability Pharma has received investment from Asabys Partners. These venture capital firms and investors provide both capital and strategic support.
Ability Pharma was founded in 2009 and is headquartered in Barcelona, Spain.
Ability Pharma operates in the Biotech sector. Spanish biopharmaceutical company developing innovative treatments for oncology and other therapeutic areas.
